Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma
Clinical trial NCT05221385 · TERMINATED
Trial details
- NCT number
- NCT05221385
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-12
- Primary completion
- 2023-05-30
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.